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Animal modelin Chianina cattle is a muscle function disorder very similar to that of Brody
disease in humans. Mutations in the human ATP2A1 gene, encoding SERCA1, cause Brody myopathy. The
analysis of the collected Chianina pedigree data suggested monogenic autosomal recessive inheritance and
revealed that all 17 affected individuals traced back to a single founder. A deﬁciency of SERCA1 function in
skeletal muscle of pseudomyotonia affected Chianina cattle was observed as SERCA1 activity in affected
animals was decreased by about 70%. Linkage analysis showed that the mutation was located in the ATP2A1
gene region on BTA25 and subsequent mutation analysis of the ATP2A1 exons revealed a perfectly associated
missense mutation in exon 6 (c.491GNA) leading to a p.Arg164His substitution. Arg164 represents a
functionally important and strongly conserved residue of SERCA1. This study provides a suitable large animal
model for human Brody disease.
© 2008 Elsevier Inc. All rights reserved.Exercise-induced muscle stiffness is an uncommon and non-
speciﬁc disorder. Exercise-induced contractures occur in muscle
glycogenosis and may belong to the spectrum of myotonia [1].
Recently, a new congenital muscular disease has been reported in
Chianina cattle designated as pseudomyotonia (PMT) as opposed to
true myotonia; in fact, the electromyographic examination does not
show any alteration, not even during the phase of the muscle
contraction [2]. The bovine disease is clinically characterized by a
lifelong history of exercise-induced muscle contracture, which
prevents animals from performing muscular activities more intense
than a simple walk at a slow pace. The disease does not affect life
expectancy. When the animals are stimulated to move fast, the
muscles immediately become stiff giving a picture of permanent
contraction; the stiffness disappears as soon as the exercise ceases
(Fig. 1). Muscle biopsies taken from PMT affected cattle after muscle
exercise showed necrotic and regenerative ﬁbers in type 2 muscle
ﬁbers [2]. The observed PMT phenotype in Chianina cattle closely
resembled the symptoms of human Brody disease [3], a rare genetic
disorder (OMIM 601003) of muscle function. Brody disease is
characterized by painless muscle contracture and exercise-induced
impairment of muscle relaxation due to a defect of calcium reuptake.
Mutations in the human ATP2A1 gene, encoding a fast-twitch skeletal-Drögemüller).
l rights reserved.muscle Ca2+-ATPase (SERCA1), cause Brody disease [4–6]. However,
similar to other muscle diseases, Brody disease in humans is
genetically heterogeneous. In some families with recessively and
dominantly inherited forms of Brody disease, no mutations in ATP2A1
have been identiﬁed [7]. In most recessive cases, nonsense, missense,
or frameshift mutations in ATP2A1 result in deleted functional
domains leading to loss of SERCA1 function of fast-twitch skeletal
muscle ﬁbers [4–6]. These ﬁndings explained earlier studies reporting
reduced Ca2+-stimulated ATPase activity and increased time required
for return to basal calcium levels following depolarization-induced
calcium release in skeletal muscle of patients with Brody disease [8].
Many inherited diseases of laboratory or domestic animals are
analogous to human hereditary disorders and have proven to be
valuable animal models both for the investigation of the pathogenesis
and therapeutic trials of rare human phenotypes with identical
molecular basis [9]. Recently, a missense mutation in bovine ATP2A1
responsible for recessive inherited congenital muscular dystonia has
been reported in Belgian Blue cattle [10]. The affected calves exhibit
episodes of generalized muscular contractures and usually die within
a fewweeks as a result of respiratory complications. Unlike the human
disease, inwhich patients survive and do not show signs of respiratory
disease, Atp2a1 null mutant mice exhibit a gasping respiration,
become cyanotic, and die shortly after birth [11]. Taken together,
until today no animal model with mutations in the ATP2A1 gene is
available, which reﬂects the mild course of human Brody disease.
Fig. 1. A 14 month-year old male PMT affected Chianina cattle during muscle exercise
test showing bunny hopping in the hind legs.
Table 1
SERCA1 activity measurements
Sample SERCA1 activity
(μmol/min/mg protein)a
Control cattleb
A 2.38±0.40
B 1.90±0.18
C 2.14±0.50
PMT affected cattlec
No. 5 0.73±0.08
No. 8 1.05±0.07
No. 9 0.17±0.06
a SERCA1 activity of sarcoplasmic reticulum enriched microsomal fractions extracted
from fast-twitch (type II) skeletal muscles was measured at 37 °C in the presence of
calcium ionophore A23187. The given values are the mean (n=3)±S.D.
b Control animals were unrelated Chianina cattle.
c Numbering corresponds to Fig. 2.
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bovine ATP2A1 in congential pseudomytonia of Chianina cattle, a
suitable animal model for studying the human Brody disease.
Results and discussion
The pedigree of an established Chianina cattle family segregating
for congenital pseudomyotonia (PMT) was consistent with monogenic
autosomal recessive inheritance (Fig. 2). Analysis of the pedigree data
from nine generations revealed that PMT occurred in different
generations but all seventeen affected calves could be traced back to
a single common male ancestor. In all cases, the parents were healthy
and the latest recorded affected calf (animal No. 27; Fig. 2) was inbred
from the probable founder sire as its parents had this bull as common
ancestor 4 or 7 generations ago, respectively.
As the PMT phenotype in Chianina cattle shows striking clinical
similarities to human Brody disease we hypothesized that mutations
in ATP2A1 might cause the bovine disease. In order to validate
whether ATP2A1 might be a reasonable functional candidate gene for
PMT, we analyzed the function of the encoded SERCA1 pump in bovine
skeletal muscles of affected and control cattle, respectively. In
sarcoplasmic reticulum enriched microsomal fractions extracted
from fast-twitch (type II) skeletal muscles, normal control cattle
displayed a mean SERCA1 activity of approximately 2.14 μmol/min/mgFig. 2. Familial relationships between the 17 individuals of Chianina cattle affected with con
heterozygous carriers and open symbols represent healthy relatives with an unknown genot
mark indicate animals, where no breeding record was available.protein and PMT affected cattle of approximately 0.65, respectively
(Table 1). This functional assay indicated that fast-twitch skeletal
muscles of PMT affected cattle showed only an activity of approxi-
mately one third of the normal values (Table 1). These data are in
agreement with reduced sarcoplasmic reticulum SERCA1 activity in
human Brody's patients, varying from 30% to 2% of controls [8,12]. In
muscle biopsies from affected Chianina cattle no reduction in ﬁbers
diameters have been described [2]. Taken together, these results
clearly demonstrated an obvious reduction of themolecular activity of
SERCA1 in skeletal muscle of PMT affected Chianina cattle and
conﬁrmed its essential role in the pseudomyotonia phenotype.
Genotyping data of two microsatellite markers derived from the
BTA25 sequencewere used for linkage analysis in the presented family
(Fig. 2). Themarkers were located approximately 170 kb upstream and
200 kb downstream of ATP2A1. The microsatellites had two and ﬁve
alleles and the calculated polymorphism information content (PIC)
was 19% and 25%, respectively (Suppl. Table 1). For linkage analysis,
the pedigree was split into three sub-pedigrees because of inbreeding
loops and the high proportion of missing DNA samples. The estimated
nonparametric maximal Z mean value of 3.3 with pb0.0005 and the
maximal parametric LOD score of 3.1 conﬁrmed the linkage of PMT to
the candidate gene region. All PMT affected calves showed homo-
zygosity for both tested markers and all genotyped parents showed at
least one copy of the disease associated haplotype. In two cases
assumed carrier parents showed two copies of this haplotype andgenital pseudomoytonia (ﬁlled symbols). Half-ﬁlled symbols represent healthy obligate
ype. DNA samples were available from numbered animals. Dams marked with question
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affected animals. Therefore, for breeding purpose an indirect PMT
genotype prediction using these two ﬂanking marker is probably
problematic due to the low information content of these markers.
After we conﬁrmed that the function of the encoded SERCA1 pump
is compatible with a role in PMT in Chianina cattle and detected
signiﬁcant genetic linkage to the bovine ATP2A1 gene, we initiated the
mutation analysis. In order to search for possible causative mutations
within ATP2A1 the available bovine mRNA sequence (Acc.
NM_001075767) was used for genomic sequence alignment with the
current BTA25 sequence to characterize the exact gene structure. The
bovine ATP2A1 gene spans 16.5 kb and consists of 23 exons (Suppl.
Table 2). All splice donor/splice acceptor sites conform to the GT/AG
rule. The coding sequence of the bovine ATP2A1 gene is contained
within 22 exons encoding the transcript corresponding to human
adult ATP2A1 isoform b. The bovine SERCA1 protein is predicted to
contain 993 amino acids with 95% identities to the human andmurine
SERCA1 proteins, respectively. Subsequently, we designed exon
spanning PCR primer pairs (Suppl. Table 2). As the current bovine
genome assembly (build 4.0) contained a gap including the entire
sequence of ATP2A1 exon 10, we submitted the obtained genomic
sequence of a 526 bp ampliﬁed PCR product containing exon 10
and ﬂanking intronic sequences into EMBL nucleotide database
(Acc. FM177181).
Mutation analysis was performed in two trios of affected calves
and their parents and in two unrelated controls of Chianina cattle.
Affected cattle carried homozygous a single base transition within
exon 6 (c.491GNA, Fig. 3a). The mutation affects an AccI recognition
site. The presence of the ATP2A1 wildtype allele G will result inFig. 3. Mutation analysis of the bovine ATP2A1 gene. (A) Sequence analysis of ge-
nomic DNA of an affected, an obligate heterozygous carrier, and an unrelated control
animal An arrow denotes the position of the mutation. Numbering of nucleotides
and codons is according to the open reading frame of the ATP2A1 cDNA sequence
(Acc. NM_001075767). (B) RFLP analysis: After digestion of the PCR product with AccI
the wildtype G-allele results in 77, 107 and 137 bp fragments, whereas the mutant A-
allele leads to 137 and 184 bp fragments. Two heterozygous carriers (C), two affected
(A), and two normal control (N) animals are shown. The undigested (u) PCR product
and a 100 bp ladder (M) are also shown.cleavage, whereas the mutant allele A will give rise to the absence of
the restriction site. A second constitutive AccI recognition site located
in the ampliﬁed product serves as a positive control (Fig. 3b). No other
mutations in exonic or splice site regions of the ATP2A1 gene were
identiﬁed in PMT affected animals. To check whether the observed
missense mutation affects ATP2A1 splicing we ampliﬁed the entire
ATP2A1 cDNA of three affected and a single control animal using
four overlapping RT-PCR products (Suppl. Table 3). No alterations of
the transcript could be observed apart from the c.491GNA poly-
morphism. We genotyped additional cattle for the exon 6 mutation
and found perfect concordance between the presence of the mutation
and the PMT phenotype in all 15 affected animals from the reported
family, while homozygous animals for the mutant allele were not
present in any of the investigated 18 healthy Chianina animals of the
presented family nor in 58 other healthy unrelated Chianina breeding
bulls. Among these 58 bulls, representing the current Italian Chianina
population, 5 PMT carriers were observed, indicating a frequency of
approximately 4% of the mutant ATP2A1 allele. The PMT mutation has
probably been introduced by the founder sire of the presented family,
as until now all identiﬁed carriers can be traced back to this Italian
Chianina artiﬁcial insemination bull named Orizio born in 1976. As
artiﬁcial insemination caused a drastic reduction of the effective
population size in Italian Chianina cattle, the recently reported
outbreak of the recessive PMT diseases gives an example that the
accompanying increase in co-ancestry and inbreeding could lead to a
quite high incidence of a genetic disease within a short time.
Therefore, we already informed the Italian Chianina breeders about
the DNA-based test for the detection of PMT carriers and they already
started to implement this information in their breeding strategy. This
new gene test identiﬁes the second breed speciﬁc mutation after the
recent identiﬁcation of the molecular cause of ichthyosis fetalis in
Italian Chianina cattle [10]. Sequencing of 30 unrelated control
animals, 10 bulls each of the cattle breeds Romagnola, Simmental,
and Brown Swiss showed that the ATP2A1 c.491GNA polymorphisms
is not present in these three breeds.
Themissense mutation leads to an amino acid exchange (p.A164H)
within a highly conserved domain of SERCA1 and affects the N-
terminal actuator domain (formerly called the transducer or beta
domain), one of the three cytosolic domains, besides the phosphor-
ylation and nucleotide-binding domains, which form the catalytic site
involved in the transmission of major conformational changes during
Ca2+and ATP binding [13]. The potential impact of this PMT associated
amino acid substitutionwas evaluated by multiple species alignments
(Fig. 4) and PolyPhen (http://genetics.bwh.harvard.edu/pph/). The
substitution affects a strongly conserved residue and was predicted to
be “probably damaging” with a PSIC score difference of 2.94, which
implies a high conﬁdence that the substitution affects protein function
or structure. It is still unclear whether the mutant protein has an
activity and a residual physiological function. A reduction in SERCA1
activity in PMT affected skeletal muscle was observed and this is most
likely due to diminished activity of the mutant SERCA1. By pumping
the calcium ions from the sarcoplasma of the muscular ﬁber back into
the sarcoplasmic reticulum, SERCA1 decreases the calcium concentra-
tion within the sarcoplasma, thereby enabling the relaxation of
myoﬁlaments. The deﬁciency of functional SERCA1 in the sarcoplas-
mic reticulum could explain the clinical presentation of the cattle.
Progressive impairment of muscle relaxation during exercise would
occur because of the cumulative increase in myoﬁbrillar Ca2+. Since
only fast-twitch muscle ﬁbers suffer from enzyme deﬁciency, it is
plausible that impaired relaxation is only noted after phasic exercise
(i.e. during strong exercise) when primarily fast-twitch motor units
are utilized. Thus, the observed mutation most likely results in the
inability of SERCA1 to keep pace with calcium release during
repetitive stimulation. By contrast, during tonic activity (such as
maintaining posture) or during slow paced walk requiring slow-
twitch motor unit activation, no obvious muscular dysfunction is
Fig. 4.Multiple sequence alignment of the SERCA1 protein in the region of the mutation
demonstrates the conservation of arginine residue 164 (R164) across species. The
observed mutation in PMT affected cattle is indicated by an arrow and the respective
position is highlighted in grey. Identical residues are indicated by asterisks beneath the
alignment, while colons and dots represent very similar and similar amino acids,
respectively.
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compensatorymechanisms apparently clear myoplasmic calcium over
time. These may include residual SERCA1 and compensatory SERCA2
activity of slow-twitch skeletal muscle, calcium extrusion via plasma
membrane Ca2+-ATPase pumps and Na+/Ca2+exchangers, as well as
mitochondrial calcium uptake [14,15].
In summary, we have applied a candidate gene approach to
identify ATP2A1 as the causative gene for PMT in Chianina cattle and
thereby discovered this new bovine genetic disorder as suitable large
animal model for human Brody disease. The PMTaffected cattle might
be very helpful in the possible identiﬁcation of new targets for
therapeutic interventions, as e.g. through injections of recombinant
SERCA1 protein. In addition, although the understanding of the
pathogenesis of the disease is still incomplete, the unique bovine
pseudomytonia phenotype provides additional information on the
role of SERCA1. The developed ATP2A1 gene test enables breeders of
Chianina cattle to get rid of this genetic disease. Taken together, this
study reﬂects the enormous potential of domestic animals to gain
further insights into mammalian biology and human medicine.
Material and methods
A total of 17 Chianina cattle (9 male, 8 female) with the clinical
diagnosis of congenital pseudomytonia were recorded. Most of these
cases could be paternally and maternally traced back to a single
common male ancestor of the established Chianina family, for the
remaining animals pedigree information was incomplete (Fig. 2).
Samples from 15 affected animals and, where possible, their sire and
dam were collected and parentage veriﬁcation was performed to
ensure correct parentage. The parents of affected offspring were
classiﬁed as obligate carriers. In total, 33 DNA samples of 15 affected
animals and 18 parents were extracted from blood, tissue, or semen
using standard molecular techniques. For RNA isolation, bovine
skeletal muscle biopsies from an unrelated control and three affected
animals were used for total RNA extraction and subsequent cDNA
synthesis using standard molecular techniques.
Preparations of skeletal muscle sarcoplasmic reticulum of biopsies
of M. semimembranosus from three PMT affected and three normal
control animals and SERCA1 activity measurements in the membrane
preparations assayed by a spectrophotometer method were per-
formed as described before [16].Microsatellite markers were ampliﬁed using the Multiplex PCR Kit
(Qiagen) and fragment size analyses were determined on an ABI 3730
capillary sequencer (Applied Biosystems, Rotkreuz, Switzerland) and
analyzed with the GeneMapper 4.0 software (Applied Biosystems).
Multipoint nonparametric linkage and parametric linkage analyses
were performed with MERLIN software version 1.1.2 [17]. For
parametric linkage, we calculated LOD scores under both homo-
geneity and heterogeneity under the assumption of PMT segregating
as a biallelic autosomal recessive trait, with complete penetrance. The
frequency of the defect allele in the considered population is unknown
and there is no data available that would make it possible to estimate
the frequency in a reliable manner. For the calculations a frequency of
0.01 for the mutated allele was assumed.
For the ATP2A1 mutation analysis suitable PCR products were
ampliﬁed using two affected, four heterozygous carrier, and two
unrelated healthy animals using AmpliTaq Gold (Applied Biosystems)
(Suppl. Table 2). The subsequent re-sequencing of the PCR products
was performed after rAPid alkaline phosphatase (Roche, Basel,
Switzerland) and exonuclease I (N.E.B., Bioconcept, Allschwil, Switzer-
land) treatment using both PCR primers with the ABI BigDye
Terminator Sequencing Kit 3.1 (Applied Biosystems) on an ABI 3730.
Sequence data were analyzed with Sequencher 4.6 (GeneCodes, Ann
Arbor, MI, USA).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ygeno.2008.07.014.
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